SCHEMBL14026314

SCHEMBL14026314

NCNC(=O)C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28929577 0.98 SMN1; SMN2 (0.53)
SCHEMBL47365 0.93 EPHX1 (0.61)
SCHEMBL7877130 0.90
Hydrochloric Acid SCHEMBL22394902 0.88
SCHEMBL4679015 0.82 NAAA (0.50)
SCHEMBL25990500 0.80 SMN1; SMN2 (0.46)
SCHEMBL47355 0.80 SMN1; SMN2 (0.41)
SCHEMBL47341 0.80 SMN1; SMN2 (0.41)
SCHEMBL13432005 0.79 NAAA (0.56)
SCHEMBL4678443 0.77 NAAA (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446097-B2 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O (HR) 2008-11-04 US disclosed